While Jalbert et al did not observe significant differences in alanine concentration in IDH‐mutant compared to IDH‐wildtype gliomas, IDH mutation is primarily observed in lower grade gliomas and they did report lower alanine levels in tissue with lower WHO grade.14 This evidence concerns the gene IDH2 and central nervous system cancer.